Martuza; Robert L.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Martuza; Robert L..The latest application filed is for "viral vectors and their use in therapeutic methods".
- Martuza; Robert L. - Cambridge MA
- Martuza; Robert L. - Marble Head MA
- Martuza; Robert L. - Chavey Chase MD
- Martuza; Robert L. - Chevy Chase MD
- Martuza; Robert L. - Marblehead MA
- Martuza; Robert L. - Lexington MA
| Patent | Date |
|---|---|
| Viral Vectors And Their Use In Therapeutic Methods App 20200345835 - Johnson; Paul ; et al. | 2020-11-05 |
| Viral vectors and their use in therapeutic methods Grant 10,532,095 - Johnson , et al. Ja | 2020-01-14 |
| Use of herpes vectors for tumor therapy Grant 9,827,307 - Rabkin , et al. November 28, 2 | 2017-11-28 |
| Viral Vectors And Their Use In Therapeutic Methods App 20170290908 - Johnson; Paul ; et al. | 2017-10-12 |
| Viral vectors and their use in therapeutic methods Grant 9,555,072 - Johnson , et al. January 31, 2 | 2017-01-31 |
| Viral Vectors And Their Use In Therapeutic Methods App 20150071965 - JOHNSON; Paul ; et al. | 2015-03-12 |
| Viral vectors and their use in therapeutic methods Grant 8,871,193 - Johnson , et al. October 28, 2 | 2014-10-28 |
| Viral Vectors And Their Use In Therapeutic Methods App 20130280299 - JOHNSON; Paul ; et al. | 2013-10-24 |
| Use Of Herpes Vectors For Tumor Therapy App 20130224243 - Rabkin; Samuel D. ; et al. | 2013-08-29 |
| Viral vectors and their use in therapeutic methods Grant 8,470,577 - Johnson , et al. June 25, 2 | 2013-06-25 |
| Use of herpes vectors for tumor therapy Grant 8,361,978 - Rabkin , et al. January 29, 2 | 2013-01-29 |
| Oncolytic herpes simplex virus immunotherapy in the treatment of brain cancer Grant 8,313,896 - Martuza , et al. November 20, 2 | 2012-11-20 |
| Replication-competent herpes simplex virus mediates destruction of neoplastic cells Grant 8,273,568 - Martuza , et al. September 25, 2 | 2012-09-25 |
| Viral Vectors and Their Use in Therapeutic Methods App 20110070262 - Johnson; Paul ; et al. | 2011-03-24 |
| Viral vectors and their use in therapeutic methods Grant 7,749,745 - Johnson , et al. July 6, 2 | 2010-07-06 |
| Cancer immunotherapy App 20090285860 - Martuza; Robert L. ; et al. | 2009-11-19 |
| Use Of Herpes Vectors For Tumor Therapy App 20090053178 - RABKIN; Samuel D. ; et al. | 2009-02-26 |
| Use of soluble costimulatory factor for tumor immuno-gene therapy Grant 7,064,111 - Todo , et al. June 20, 2 | 2006-06-20 |
| Use of herpes vectors for tumor therapy App 20050232907 - Rabkin, Samuel D. ; et al. | 2005-10-20 |
| Replication-competent herpes simplex virus mediates destruction of neoplastic cells App 20040151697 - Martuza, Robert L. ; et al. | 2004-08-05 |
| Viral mutant HSV mediated destruction of neoplastic cells Grant 6,770,274 - Martuza , et al. August 3, 2 | 2004-08-03 |
| Replication-competent herpes simplex virus mediates destruction of neoplastic cells Grant 6,699,468 - Martuza , et al. March 2, 2 | 2004-03-02 |
| Transfer and expression of gene sequences into nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication Grant 6,610,287 - Breakefield , et al. August 26, 2 | 2003-08-26 |
| Viral vectors and their use in therapeutic methods App 20020187163 - Johnson, Paul ; et al. | 2002-12-12 |
| Use of herpes vectors for tumor therapy App 20020127246 - Rabkin, Samuel D. ; et al. | 2002-09-12 |
| Use of herpes vectors for tumor therapy Grant 6,379,674 - Rabkin , et al. April 30, 2 | 2002-04-30 |
| Tumor- or cell-specific herpes simplex virus replication Grant 5,728,379 - Martuza , et al. March 17, 1 | 1998-03-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 